来自Salvia castanea的多种结构和多功能神经保护作用的阿比坦二维
Liang Yang1, Gui-Rong Wei1, Yun-Ji Cao1
1Department of Pharmacy, Loudi Central Hospital, Hunan Province, Loudi 417000, PR China.
来自Salvia castanea的甲基坦西诺酸显示出抗神经炎症作用,并在阿尔茨海默氏症模型中延迟. 它还促进神经细胞的生长,为神经退行性疾病的治疗提供了潜力.
科学领域:
- 自然产品化学 自然产品化学
- 神经药理学神经药理学
- 药用化学 医学化学
背景情况:
- 在西藏医学中,Salvia castanea是丹申的替代品,是生物活性化合物的来源.
- 像阿尔茨海默氏症这样的神经退行性疾病对健康构成重大挑战,需要寻找新的治疗药物.
研究的目的:
- 从Salvia castanea中分离和特征化二类植物.
- 评估隔离化合物对神经炎症,阿尔茨海默病模型的神经保护潜力,并评估它们对神经细胞外生长的影响.
主要方法:
- 使用NMR光谱学分离并阐明12个特特类的结构.
- 在体外测定抗神经炎症活性 (iNOS,COX-2,NF-κB p65酸化).
- 在Caenorhabditis elegans模型中进行的阿尔茨海默病和PC-12细胞基神经元外生长试验的体内研究.
主要成果:
- 甲基坦西诺酸 (1) 通过抑制 iNOS,COX-2 和 NF-κB p65 酸化,显示出抗神经炎症的活性.
- 化合物1,2,4和6延迟了C. elegans中Aβ诱导的,而化合物1和2减少了ROS积累.
- 化合物1和2显著促进了PC-12细胞中NGF诱导的神经元的生长,而化合物2与单独NGF相比显著增加了3倍.
结论:
- 萨尔维亚·卡斯塔尼亚 (Salvia castanea) 产生具有显著神经保护性质的双类物质.
- 甲基坦西诺酸和相关化合物显示出作为神经退行性疾病的潜在治疗剂的前景.
- 这些已识别的化合物为开发针对神经炎症和神经元损伤的新疗法提供了基础.
更多相关视频
10:25Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
Published on: November 22, 2024
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
相关概念视频
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Alzheimer's Disease: Treatment
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
